Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Apollo Healthcare Corp Warrants (03/01/2022) APHWF

Based in Ontario Canada the Apollo Healthcare Corp Apollo is one of the largest private label personal care product manufacturers in North America developing and manufacturing retailer branded and private label products for major North American retailers. Apollos products are sold in tens of thousands of stores across North America and its customer base spans across major North American grocery drug and mass merchandise retailers users as well as wholesale clubs. In addition to private label Apollo also manufactures products on a contract basis for many of its clients.


OTCPK:APHWF - Post by User

Comment by deleuze68on Feb 11, 2021 12:05am
145 Views
Post# 32534445

RE:RE:RE:RE:RE:RE:RE:Weak Hands

RE:RE:RE:RE:RE:RE:RE:Weak HandsThere are actually severe barriers of entry. Big box stores are only willing to deal with suppliers that are reliable and can guarantee uninterupted supply of product. Apollo has developed relationships over decades with these stores and proved that they could meet their demand. How many manufacturing facilities in Canada have their own rail spur? This is the premier facility in Canada and possibly North America for private label products. Sales have increased twofold during the pandemic not just because of increased demand, but most importantly because the big box stores during the pandemic preferred to deal with a supplier that was most likely to meet this demand. These expanded relationships are not going to disappear. The pandemic has not provided a temporary boost for Apollo, but rather fueled future growth by solidifying their moat.

I'm not suggesting earnings will remain at these elevated levels into the future but they really don't need to in order for Apollo to be considered dirt cheap. Even if earnings are cut in half (from $1.40 annualized to $0.70 annualized) as a private label consumer staples company it should still command a P/E of at least 15 which would put the share price at $10.50, more than a double from here.
<< Previous
Bullboard Posts
Next >>